Pharma News

Unichem Laboratories has received final approval from the US health regulator to market generic Irbesartan tablets, used in treating hypertension, in the American market.

Takeda Pharmaceutical Company Limited announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing that treatment with NINLARO® (ixazomib) capsules is effective in extending progression free survival (PFS) with a manageable tolerability profile in patients with relapsed and/or refractory multiple myeloma. The TOURMALINE-MM1 trial is an international, randomized, double-blind, placebo-controlled Phase 3 clinical trial designed to evaluate once-weekly oral ixazomib plus lenalidomide and dexamethasone compared to placebo plus lenalidomide and dexamethasone.

AstraZeneca announced plans to test a digital support service for women undergoing treatment for recurrent platinum-sensitive high-grade ovarian cancer in clinical trials of cediranib plus olaparib. Voluntis has developed the service in close clinical collaboration with AstraZeneca and the US National Cancer Institute (NCI). It is delivered through a smartphone app paired with a web portal to help clinicians and patients manage side effects of hypertension and diarrhoea sometimes associated with combination therapy with cediranib and olaparib. Such side effects are traditionally described to care teams through manual, time-consuming and non-digitised channels.

Some doctors may recommend that patients with the flu take acetaminophen, or paracetemol, to relieve their symptoms; however, a new randomized clinical trial found no benefits to the over-the-counter medication in terms of fighting the influenza virus or reducing patients' temperature or other symptoms.

Are you a green tea lover? Read this carefully as the cup packed with anti-oxidants and other health benefits may adversely affect your fertility and development in case of frequent use, warn researchers.

Scientists have deployed a new drug discovery technique to identify an anti-diabetes compound with a novel mechanism of action. The finding by the Scripps Research Institute (TSRI), US, may lead to a new type of diabetes treatment by enabling researchers quickly find drug candidates that activate cellular receptors in desired ways.

[adsense:336x280:8701650588]

For the first time, researchers led by the Imperial College London, have genetically modified malarial mosquitoes so that they carry a gene that disrupts egg production in female mosquitoes.

Men diagnosed with infertility are at higher risk of diabetes, heart disease, alcohol abuse and drug abuse compared to fertile men, a new study has revealed.

Dr. Reddy ’s announced  the signing of a Memorandum of Understanding  (MoU) with The Life Sciences Sector  Skill Development Council  (LSSSDC)  and  Vishnu  Institute of Pharmaceutical Education and Research (VIPER) .The MoU is aimed at fostering market research collaboration between LSSSDC and industry par tners , that in turn will help align educational courses to industry requirements.The MoU will also collaborate to create pharmaceutical,biotechnology and clinical research occupation standards, as well as establish acompetency matrix for job roles in the pharmaceutical sector.